Home Considering a new standard of care in schizophrenia As a psychiatrist, I have observed that schizophrenia is a widely known, but poorly understood mental health condition.
News NHSBSA releases latest Medicines Used in Mental Health data Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.
News Intellia files CRISPR drug after historic phase 3 readout Intellia has reported the first-ever phase 3 results with an in vivo gene-editing therapy, CRISPR-based lonvo-z for hereditary angioedema.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
